Market Closed -
OTC Markets
12:15:42 28/06/2024 am IST
|
5-day change
|
1st Jan Change
|
0.028
USD
|
-26.12%
|
|
-24.93%
|
-30.00%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
26.53
|
21.83
|
21.64
|
47.23
|
16.73
|
20.79
|
Enterprise Value (EV)
1 |
31.01
|
29.51
|
29.67
|
55.94
|
22.47
|
26.45
|
P/E ratio
|
-31.3
x
|
-14.3
x
|
9.8
x
|
-49.8
x
|
54.8
x
|
-23.8
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
2.56
x
|
2.44
x
|
2.31
x
|
4.89
x
|
1.5
x
|
1.69
x
|
EV / Revenue
|
2.99
x
|
3.3
x
|
3.17
x
|
5.79
x
|
2.01
x
|
2.16
x
|
EV / EBITDA
|
4,307
x
|
-117
x
|
-401
x
|
146
x
|
-28.9
x
|
-70.9
x
|
EV / FCF
|
30
x
|
-11.3
x
|
41.5
x
|
-96.9
x
|
-14.3
x
|
47.1
x
|
FCF Yield
|
3.33%
|
-8.86%
|
2.41%
|
-1.03%
|
-7%
|
2.12%
|
Price to Book
|
-16.5
x
|
-9.99
x
|
37.7
x
|
17.3
x
|
3.85
x
|
5.15
x
|
Nbr of stocks (in thousands)
|
4,13,168
|
4,19,842
|
4,24,344
|
5,02,468
|
5,14,890
|
5,19,788
|
Reference price
2 |
0.0642
|
0.0520
|
0.0510
|
0.0940
|
0.0325
|
0.0400
|
Announcement Date
|
19/03/19
|
30/03/20
|
30/03/21
|
31/03/22
|
06/04/23
|
29/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
10.37
|
8.955
|
9.365
|
9.662
|
11.18
|
12.27
|
EBITDA
1 |
0.007199
|
-0.2517
|
-0.074
|
0.3837
|
-0.7784
|
-0.3731
|
EBIT
1 |
-0.2901
|
-0.5583
|
-0.4157
|
-0.2408
|
-1.203
|
-0.7763
|
Operating Margin
|
-2.8%
|
-6.23%
|
-4.44%
|
-2.49%
|
-10.76%
|
-6.33%
|
Earnings before Tax (EBT)
1 |
-0.6639
|
-1.201
|
2.443
|
-0.789
|
0.3032
|
-0.869
|
Net income
1 |
-0.8446
|
-1.523
|
2.203
|
-0.9023
|
0.3032
|
-0.869
|
Net margin
|
-8.15%
|
-17.01%
|
23.52%
|
-9.34%
|
2.71%
|
-7.08%
|
EPS
2 |
-0.002054
|
-0.003642
|
0.005206
|
-0.001888
|
0.000593
|
-0.001678
|
Free Cash Flow
1 |
1.033
|
-2.615
|
0.7145
|
-0.5772
|
-1.573
|
0.5613
|
FCF margin
|
9.96%
|
-29.21%
|
7.63%
|
-5.97%
|
-14.07%
|
4.58%
|
FCF Conversion (EBITDA)
|
14,348.6%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
32.44%
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
19/03/19
|
30/03/20
|
30/03/21
|
31/03/22
|
06/04/23
|
29/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
4.48
|
7.68
|
8.03
|
8.71
|
5.74
|
5.66
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
622.8
x
|
-30.52
x
|
-108.5
x
|
22.69
x
|
-7.37
x
|
-15.16
x
|
Free Cash Flow
1 |
1.03
|
-2.62
|
0.71
|
-0.58
|
-1.57
|
0.56
|
ROE (net income / shareholders' equity)
|
-265%
|
-5,721%
|
176%
|
-28.1%
|
8.57%
|
-20.7%
|
ROA (Net income/ Total Assets)
|
-1.45%
|
-2.47%
|
-1.61%
|
-0.9%
|
-4.62%
|
-2.93%
|
Assets
1 |
58.23
|
61.64
|
-137.2
|
100.2
|
-6.569
|
29.69
|
Book Value Per Share
2 |
-0
|
-0.0100
|
0
|
0.0100
|
0.0100
|
0.0100
|
Cash Flow per Share
2 |
0
|
0
|
0
|
0
|
0
|
0.0100
|
Capex
1 |
0.09
|
0.21
|
0.01
|
0.21
|
0.12
|
0.15
|
Capex / Sales
|
0.83%
|
2.32%
|
0.08%
|
2.13%
|
1.07%
|
1.22%
|
Announcement Date
|
19/03/19
|
30/03/20
|
30/03/21
|
31/03/22
|
06/04/23
|
29/03/24
|
|
1st Jan change
|
Capi.
|
---|
| -30.00% | 14.64M | | +26.94% | 8.77B | | +12.03% | 8.03B | | +20.72% | 5.48B | | +13.27% | 3.71B | | -19.32% | 3.46B | | +3.41% | 3.4B | | +17.68% | 3.38B | | -10.25% | 2.7B | | +4.78% | 2.22B |
Testing & Measuring Equipment
|